Skip to main content

Market Overview

Barclays Thinks Intuitive Surgical Is Still Worth $650


Barclays noted that Intuitive Surgical, Inc. (NASDAQ: ISRG) is still valued at $650. In a research note on Friday, Barclays maintained an Overweight rating on the stock commenting, "net-net, this was another excellent quarter and overall, we think ISRG's opportunities outweigh the risks."

Intuitive Surgical released its Q42015 results on Thursday, revealing that its pro-forma revenue grew ~13 percent year over year.

"By segment, instrument and accessory revenue of $231 million was in line with our $229 million service revenue of $120 million," the firm noted. "EPS was $5.89, above consensus expectations and helped by $0.17 for the R&D tax credit."

Commentary Not Surprising

Intuitive Surgical's 2016 commentary was "relatively unsurprising."

Intuitive Surgical's only exception was its op-ex guidance of a 9 to 13 percent increase. "While 2015 started with both procedure and OpX guidance of +7-10 percent, by the end of the year, ISRG was expecting to grow procedures 13-14 percent and OpX only 7 percent generating significant leverage," the firm added.

Latest Ratings for ISRG

Jan 2021Raymond JamesMaintainsOutperform
Dec 2020Morgan StanleyDowngradesOverweightEqual-Weight
Oct 2020SVB LeerinkMaintainsMarket Perform

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings


Related Articles (ISRG)

View Comments and Join the Discussion!

Posted-In: BarclaysAnalyst Color Biotech Long Ideas Health Care Analyst Ratings Trading Ideas General

Latest Ratings

NIUDaiwa CapitalInitiates Coverage On41.5
QMCONorthland Capital MarketsInitiates Coverage On12.0
IBKRJefferiesInitiates Coverage On89.0
MRETFTD SecuritiesDowngrades18.5
SWKSGoldman SachsDowngrades135.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at